Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; APAS Analysis Modules, a software algorithm that enables the screening of microbiology culture plates collected during environmental monitoring; and APAS PharmaQC, an artificial intelligence for culture plate reading. It also develops APAS intelligent imaging technology for various applications, which includes wound treatment, histopathology, and antimicrobial susceptibility testing. The company was formerly known as LBT Innovations Limited and changed its name to Clever Culture Systems Limited in November 2024. Clever Culture Systems Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.
Metrics to compare | CC5 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCC5PeersSector | |
---|---|---|---|---|
P/E Ratio | −8.5x | −5.2x | −0.6x | |
PEG Ratio | −0.09 | −0.12 | 0.00 | |
Price/Book | 13.1x | 2.9x | 2.6x | |
Price / LTM Sales | 25.2x | 2.9x | 3.1x | |
Upside (Analyst Target) | - | 29.0% | 51.5% | |
Fair Value Upside | Unlock | 2.3% | 8.4% | Unlock |